Measurement of Glycine in the Human Brain in Vivo by 1H-MRS at 3 T: Application in Brain Tumors

Overview

Journal Magn Reson Med

Publisher Wiley

Specialty Radiology

Date 2011 Mar 12

PMID 21394775

Citations 29

Authors

Changho Choi

Sandeep K Ganji

Ralph J DeBerardinis

Ivan E Dimitrov

Juan M Pascual

Robert Bachoo

Bruce E Mickey

Craig R Malloy

Elizabeth A Maher

Affiliations

Soon will be listed here.

Abstract

Glycine is a key metabolic intermediate required for the synthesis of proteins, nucleic acids, and other molecules, and its detection in cancer could, therefore, provide biologically relevant information about the growth of the tumor. Here, we report measurement of glycine in human brain and gliomas by an optimized point-resolved spectroscopy sequence at 3 T. Echo time dependence of the major obstacle, myo-inositol (mI) multiplet, was investigated with numerical simulations, incorporating the 3D volume localization. The simulations indicated that a subecho pair (TE(1) , TE(2) ) = (60, 100) ms permits detection of both glycine and mI with optimum selectivity. In vivo validation of the optimized point-resolved spectroscopy was conducted on the right parietal cortex of five healthy volunteers. Metabolite signals estimated from LC Model were normalized with respect to the brain water signal, and the concentrations were evaluated assuming the total creatine concentration at 8 mM. The glycine concentration was estimated as 0.6 ± 0.1 mM (mean ± SD, n = 5), with a mean Cramér-Rao lower bound of 9 ± 1%. The point-resolved spectroscopy sequence was applied to measure the glycine levels in patients with glioblastoma multiforme. Metabolite concentrations were obtained using the water signal from the tumor mass. The study revealed that a subset of human gliomas contains glycine levels elevated 1.5-8 fold relative to normal.

Citing Articles

Neurochemical dynamics during two hypnotic states evidenced by magnetic resonance spectroscopy.

de Matos N, Staempfli P, Zoelch N, Seifritz E, Bruegger M Sci Rep. 2024; 14(1):29952.

PMID: 39622963 PMC: 11612407. DOI: 10.1038/s41598-024-80795-3.

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.

Alcicek S, Pilatus U, Manzhurtsev A, Weber K, Ronellenfitsch M, Steinbach J J Neurooncol. 2024; 170(2):451-461.

PMID: 39192067 PMC: 11538230. DOI: 10.1007/s11060-024-04803-2.

Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.

Shelkowitz E, Saneto R, Al-Hertani W, Lubout C, Stence N, Brown M Orphanet J Rare Dis. 2022; 17(1):423.

PMID: 36471344 PMC: 9720968. DOI: 10.1186/s13023-022-02581-6.

GlyCEST: Magnetic Resonance Imaging of Glycine-Distribution in the Normal Murine Brain and Alterations in 5xFAD Mice.

Ohno K, Ohkubo M, Zheng B, Watanabe M, Matsuda T, Kwee I Contrast Media Mol Imaging. 2022; 2021:8988762.

PMID: 35046756 PMC: 8739925. DOI: 10.1155/2021/8988762.

Magnetic resonance spectroscopy for the study of cns malignancies.

Ruiz-Rodado V, Brender J, Cherukuri M, Gilbert M, Larion M Prog Nucl Magn Reson Spectrosc. 2021; 122:23-41.

PMID: 33632416 PMC: 7910526. DOI: 10.1016/j.pnmrs.2020.11.001.

References

Eulenburg V, Armsen W, Betz H, Gomeza J . Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci. 2005; 30(6):325-33. DOI: 10.1016/j.tibs.2005.04.004. View

Ogg R, Kingsley P, Taylor J . WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B. 1994; 104(1):1-10. DOI: 10.1006/jmrb.1994.1048. View

Kaufman M, Prescot A, Ongur D, Evins A, Barros T, Medeiros C . Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study. Psychiatry Res. 2009; 173(2):143-9. PMC: 2713375. DOI: 10.1016/j.pscychresns.2009.03.004. View

Kinoshita Y, Yokota A . Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10(1):2-12. DOI: 10.1002/(sici)1099-1492(199701)10:1<2::aid-nbm442>3.0.co;2-n. View

Lehnhardt F, Bock C, Rohn G, Ernestus R, Hoehn M . Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed. 2005; 18(6):371-82. DOI: 10.1002/nbm.968. View

Mlynarik V, Gruber S, Moser E . Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001; 14(5):325-31. DOI: 10.1002/nbm.713. View

Gambarota G, Mekle R, Xin L, Hergt M, van der Zwaag W, Krueger G . In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T. MAGMA. 2008; 22(1):1-4. DOI: 10.1007/s10334-008-0152-0. View

Kaiser L, Young K, Matson G . Numerical simulations of localized high field 1H MR spectroscopy. J Magn Reson. 2008; 195(1):67-75. PMC: 2585774. DOI: 10.1016/j.jmr.2008.08.010. View

Choi C, Lee H, Yoon J . Localized proton MR spectroscopic detection of nonketotic hyperglycinemia in an infant. Korean J Radiol. 2002; 2(4):239-42. PMC: 2718128. DOI: 10.3348/kjr.2001.2.4.239. View

10.

Choi C, Coupland N, Kalra S, Bhardwaj P, Malykhin N, Allen P . Proton spectral editing for discrimination of lactate and threonine 1.31 ppm resonances in human brain in vivo. Magn Reson Med. 2006; 56(3):660-5. DOI: 10.1002/mrm.20988. View

11.

Tkac I, Oz G, Adriany G, Ugurbil K, Gruetter R . In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med. 2009; 62(4):868-79. PMC: 2843548. DOI: 10.1002/mrm.22086. View

12.

Davies N, Wilson M, Natarajan K, Sun Y, Macpherson L, Brundler M . Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed. 2009; 23(1):80-7. DOI: 10.1002/nbm.1432. View

13.

Barker P, Breiter S, Soher B, Chatham J, Forder J, Samphilipo M . Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med. 1994; 32(2):157-63. DOI: 10.1002/mrm.1910320202. View

14.

Javitt D . Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol. 2007; 78:69-108. DOI: 10.1016/S0074-7742(06)78003-5. View

15.

Choi C, Coupland N, Bhardwaj P, Kalra S, Casault C, Reid K . T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med. 2006; 56(5):971-7. DOI: 10.1002/mrm.21055. View

16.

Prescot A, Frederick B, Wang L, Brown J, Jensen J, Kaufman M . In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med. 2006; 55(3):681-6. DOI: 10.1002/mrm.20807. View

17.

Govindaraju V, Young K, Maudsley A . Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3):129-53. DOI: 10.1002/1099-1492(200005)13:3<129::aid-nbm619>3.0.co;2-v. View

18.

Nikiforov M, Chandriani S, OConnell B, Petrenko O, Kotenko I, Beavis A . A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol. 2002; 22(16):5793-800. PMC: 133987. DOI: 10.1128/MCB.22.16.5793-5800.2002. View

19.

Florian C, Preece N, Bhakoo K, Williams S, Noble M . Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed. 1995; 8(6):253-64. DOI: 10.1002/nbm.1940080605. View

20.

Marjanska M, Henry P, Ugurbil K, Gruetter R . Editing through multiple bonds: threonine detection. Magn Reson Med. 2008; 59(2):245-51. DOI: 10.1002/mrm.21492. View